Fluorescence activated cell sorting (FACS) using RNAlater to minimize RNA degradation and perturbation of mRNA expression from cells involved in initial host microbe interactions

Journal of Microbiological Methods

Volumn 70, Issue 1, 2007, Pages 205-208

  Nishimoto, Kevin P ^a   Newkirk, Daniel ^b   Hou, Stephen ^b   Fruehauf, John ^b   Nelson, Edward L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fluorescence activated cell sorting; Gene expression profile; Host microbe interactions; RNA

Indexed keywords

MESSENGER RNA; RNA;

ARTICLE; DNA FLANKING REGION; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION PROFILING; METHODOLOGY; NONHUMAN; PLANT GROWTH; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA DEGRADATION;

CELLS, CULTURED; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTES, MONONUCLEAR; RNA STABILITY; RNA, MESSENGER;

EID: 34250764675     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mimet.2007.03.022     Document Type: Article

References (9)

1. Arbibe L., Kim D.W., Batsche E., Pedron T., Mateescu B., Muchardt C., Parsot C., and Sansonetti P.J. An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat. Immunol. 8 (2007) 47-56
2. Barrett M.T., Glogovac J., Porter P., Reid B.J., and Rabinovitch P.S. High yields of RNA and DNA suitable for array analysis from cell sorter purified epithelial cell and tissue populations. Nat. Genet. 23 (1999) 32-33
3. Barrett, M.T., Glogovac, J., Prevo, L.J., Reid, B.J., Porter, P., Rabinovitch, P.S., 2002. High-quality RNA and DNA from flow cytometrically sorted human epithelial cells and tissues. Biotechniques. 32, 888-90, 892, 894, 896.
4. Estrada B., Choe S.E., Gisselbrecht S.S., Michaud S., Raj L., Busser B.W., Halfon M.S., Church G.M., and Michelson A.M. An integrated strategy for analyzing the unique developmental programs of different myoblast subtypes. PLoS Genet. 2 (2006) e16
5. Grotzer M.A., Patti R., Geoerger B., Eggert A., Chou T.T., and Phillips P.C. Biological stability of RNA isolated from RNAlater-treated brain tumor and neuroblastoma xenografts. Med. Pediatr. Oncol. 34 (2000) 438-442
6. Lorell S.R., Coffin C.M., Holden J.A., Zimmermann J.W., Gerwels J.W., Summers B.K., Jones D.A., and Leachman S.A. Preservation of RNA for functional genomics studies: a multidisciplinary tumor bank protocol. Mod. Path. 14 (2001) 116-128
7. Moran T.P., Collier M., McKinnon K.P., Davis N.L., Johnston R.E., and Serody J.S. A novel viral system for generating antigen-specific T cells. J. Immunol. 175 (2005) 3431-3438
8. Pushko P., Parker M., Ludwig G.V., Davis N.L., Johnston R.E., and Smith J.F. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology 239 (1997) 389-401
9. Wang W.-H., McNatt L.G., Shepard A.R., Jacobson N., Nishimura D.Y., Stone E.M., Sheffield V.C., and Clark A.F. Optimal procedure for extracting RNA from human ocular tissues and expression profiling of the congenital glaucoma gene FOXC1 using quantitative PCR. Mol. Vis. 7 (2001) 89-94